Stryker Warren Insider Profile
4 Followers
Stryker Warren, CEO, Director at Urologix, holds 457.28K shares in Urologix (Ticker: ULGX). Most recently, Stryker Warren Bought 200,000 shares of Urologix on Jul 02, 2012 for an estimated value of $150.00K.
Stryker Warren's Trading History
| ULGXUrologix | Jul 02, 2012 | CEO, Director | Informative Buy | 150.00K | $6.86K | |
ULGX Insider Shares: 457.28K (2.19%) | ||||||
You May Also Like
Stryker Warren insider profile FAQ
What is the percentage of profitable transactions made by Stryker Warren?
The percentage of profitable transactions made by Stryker Warren is 38%.
What is the average return per transaction made by Stryker Warren?
The average return per transaction made by Stryker Warren is -5.00%.
What stocks does Stryker Warren hold?
Stryker Warren holds: ULGX stocks.
What was Stryker Warren’s latest transaction?
Stryker Warren’s latest transaction was an Informative Buy of $150.00K.
What was Stryker Warren's most profitable transaction?
Stryker Warren’s most profitable transaction was an Informative Buy of ULGX stock on February 1, 2011. The return on the trade was 80.60%.
What is Stryker Warren's role in Urologix?
Stryker Warren's role in Urologix is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
